— Know what they know.
Not Investment Advice

CTEV NYSE

Claritev Corporation
1W: +1.1% 1M: +0.7% 3M: -3.3% YTD: -33.2% 1Y: -67.5% 3Y: -63.0% 5Y: -88.9%
$22.65
+1.11 (+5.15%)
 
Weekly Expected Move ±8.6%
$19 $21 $24 $26 $28
NYSE · Healthcare · Medical - Healthcare Information Services · Tech Score Sell · Power 40 · $383.9M mcap · 7M float · 2.16% daily turnover · Short 45% of daily vol
Credit Risk of going bust: higher than 96% of companies Debt: 92.3% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the riskiest tenth, about 1 in 20 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $19.38 (down 14%), Claritev Corporation would be worth roughly what it owes.
Total debt $4.62B against a stock market value of $383.9M.
Distance to default 0.10 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $2.32B (short-term plus half of long-term), stock volatility 127.1%; Altman Z'' -1.71. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$4.9B -5.1% ▼
5Y CAGR: -10.0%
Total Liabilities
$5.1B -0.2% ▼
5Y CAGR: -2.5%
Shareholders Equity
-$174M -307.0% ▼
Cash & Investments
$17M -0.2% ▼
5Y CAGR: -33.2%
Total Debt
$4.6B +2.0% ▲
5Y CAGR: +0.1%
Net Debt
$4.6B +2.0% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$185M$334M$72M$17M$17M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$185M$334M$72M$17M$17M
Net Receivables$100M$79M$85M$112M$138M
Inventory$0$0$0$0$0
Other Current Assets$4M$10M$12M$20M$69M
Total Current Assets$319M$447M$194M$176M$224M
Property, Plant & Equip.$243M$257M$287M$309M$340M
Goodwill & Intangibles$7.6B$6.6B$6.5B$4.6B$4.3B
Long-Term Investments$0$0$0$15M$0
Other Non-Current Assets$10M$22M$22M$22M$33M
Total Non-Current Assets$7.9B$6.9B$6.8B$5.0B$4.7B
Total Assets$8.2B$7.4B$7.0B$5.2B$4.9B
— Liabilities —
Accounts Payable$13M$13M$20M$86M$60M
Short-Term Debt$13M$13M$13M$13M$19M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$25M$35M$45M$34M$182M
Total Current Liabilities$142M$176M$167M$214M$261M
Long-Term Debt$4.9B$4.7B$4.5B$4.5B$4.6B
Other Non-Current Liab.$74M$2M$17M$4M-$16M
Total Non-Current Liabilities$5.7B$5.4B$5.1B$4.9B$4.8B
Total Liabilities$5.9B$5.6B$5.3B$5.1B$5.1B
— Equity —
Common Stock$67K$67K$2K$2K$2K
Retained Earnings$225M-$348M-$499M-$2.1B-$2.4B
Accumulated OCI$0$0-$12M-$5M-$4M
Total Stockholders Equity$2.3B$1.8B$1.7B$84M-$174M
Total Liabilities & Equity$8.2B$7.4B$7.0B$5.2B$4.9B
— Key Metrics —
Total Debt$4.9B$4.8B$4.6B$4.5B$4.6B
Net Debt$4.7B$4.4B$4.5B$4.5B$4.6B
Total Investments$0$0$0$15M$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms